Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

10X Genomics Inc
NASDAQ:TXG

Watchlist Manager
10X Genomics Inc Logo
10X Genomics Inc
NASDAQ:TXG
Watchlist
Price: 75.56 USD -6.37% Market Closed
Market Cap: $9.6B
Write Note Create Alert Ask AI

Wall St Price Targets

TXG Price Forecast
Based on 16 analysts

-33% Downside
from $75.56 today

TXG Analyst Rating
Based on 16 analysts

Strong buy
5 31%
Buy
2 13%
Hold
9 56%
Sell
0 0%
Strong sell
0 0%
10X Genomics Inc Competitors:
Price Targets

Revenue
Forecast

24% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
24% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 7 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 8 years is 10%.

What are analyst estimates?

Gross Profit
Forecast

21% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
21% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 7 years, the compound annual growth rate for Gross Profit has been 21%. The projected CAGR for the next 8 years is 10%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

What are analyst estimates?

Continue TXG Research

Summary
TXG intrinsic value, competitors valuation, and company profile.
DCF Valuation
TXG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TXG stock valuation using valuation multiples.
Wall St Estimates
TXG price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TXG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other 10X Genomics Inc listings:
F • EUR
1KJ
 LSE • USD
0A88
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TXG's stock price target?
Price Target
51 USD

According to Wall Street analysts, the average 1-year price target for TXG is 51 USD with a low forecast of 40.4 USD and a high forecast of 73.5 USD.

What is the Revenue forecast for 10X Genomics Inc?
Projected CAGR
10%

Over the last 7 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 8 years is 10%.

What is the Gross Profit forecast for 10X Genomics Inc?
Projected CAGR
10%

Over the last 7 years, the compound annual growth rate for Gross Profit has been 21%. The projected CAGR for the next 8 years is 10%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.